Mercodia is a world-leading manufacturer of cardiometabolic immunoassays using our 30+ years of experience to provide tailored bioanalysis solutions for pharma and biotech companies. We specialize in assay development and validation, PK/PD, immunogenicity testing, and biomarker analysis, mainly focusing on large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. We are GLP-certified and work in accordance with ICH GCP, EMA, and FDA guidelines.
Mercodia’s vision is to improve human health by offering our products and services to scientists around the globe. Our team of experts quickly provides reproducible, reliable, and high-quality data that meets regulatory requirements. We prioritize speed and flexibility while delivering cost-effective solutions and are a trusted partner to some of the most renowned universities, pharmaceutical, and biotech companies worldwide.